2022
Comparative analysis of transcriptomic points-of-departure (tPODs) and apical responses in embryo-larval fathead minnows exposed to fluoxetine
ALCARAZ, Alper James G., Shaina BARANIUK, Kamil MIKULÁŠEK, Bradley PARK, Taylor LANE et. al.Základní údaje
Originální název
Comparative analysis of transcriptomic points-of-departure (tPODs) and apical responses in embryo-larval fathead minnows exposed to fluoxetine
Autoři
ALCARAZ, Alper James G. (124 Kanada), Shaina BARANIUK (124 Kanada), Kamil MIKULÁŠEK (203 Česká republika, domácí), Bradley PARK (124 Kanada), Taylor LANE (124 Kanada), Connor BURBRIDGE (124 Kanada), Jessica EWALD (124 Kanada), David POTĚŠIL (203 Česká republika, domácí), Jianguo XIA (124 Kanada), Zbyněk ZDRÁHAL (203 Česká republika, garant, domácí), David SCHNEIDER (124 Kanada), Doug CRUMP (124 Kanada), Niladri BASU (124 Kanada), Natacha HOGAN (124 Kanada), Markus BRINKMANN (124 Kanada) a Markus HECKER (124 Kanada)
Vydání
ENVIRONMENTAL POLLUTION, ENGLAND, ELSEVIER SCI LTD, 2022, 0269-7491
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
10511 Environmental sciences
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 8.900
Kód RIV
RIV/00216224:14740/22:00125954
Organizační jednotka
Středoevropský technologický institut
UT WoS
000760279500002
Klíčová slova anglicky
Benchmark dose (BMD); Selective serotonin reuptake inhibitor (SSRI); Hazard assessment; Live-animal alternatives; New approach methodology (NAM)
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 2. 11. 2024 21:07, Ing. Martina Blahová
Anotace
V originále
Current approaches in chemical hazard assessment face significant challenges because they rely on live animal testing, which is time-consuming, expensive, and ethically questionable. These concerns serve as an impetus to develop new approach methodologies (NAMs) that do not rely on live animal tests. This study explored a molecular benchmark dose (BMD) approach using a 7-day embryo-larval fathead minnow (FHM) assay to derive transcriptomic points-of-departure (tPODs) to predict apical BMDs of fluoxetine (FLX), a highly prescribed and potent selective serotonin reuptake inhibitor frequently detected in surface waters. Fertilized FHM embryos were exposed to graded concentrations of FLX (confirmed at < LOD, 0.19, 0.74, 3.38, 10.2, 47.5 mu g/L) for 32 days. Subsets of fish were subjected to omics and locomotor analyses at 7 days post-fertilization (dpf) and to histological and biometric measurements at 32 dpf. Enrichment analyses of transcriptomics and proteomics data revealed significant perturbations in gene sets associated with serotonergic and axonal functions. BMD analysis resulted in tPOD values of 0.56 mu g/L (median of the 20 most sensitive gene-level BMDs), 5.0 mu g/L (tenth percentile of all gene-level BMDs), 7.51 mu g/L (mode of the first peak of all gene-level BMDs), and 5.66 mu g/L (pathway-level BMD). These tPODs were protective of locomotor and reduced body weight effects (LOEC of 10.2 mu g/L) observed in this study and were reflective of chronic apical BMDs of FLX reported in the literature. Furthermore, the distribution of gene-level BMDs followed a bimodal pattern, revealing disruption of sensitive neurotoxic pathways at low concentrations and metabolic pathway perturbations at higher concentrations. This is one of the first studies to derive protective tPODs for FLX using a short-term embryo assay at a life stage not considered to be a live animal under current legislations.
Návaznosti
LM2018140, projekt VaV |
| ||
LQ1601, projekt VaV |
| ||
90127, velká výzkumná infrastruktura |
|